CompletedNot Applicable

Preventive Physiotherapy Intervention in Elderly People With Sarcopenia

Spain91 participantsStarted 2014-01

Plain-language summary

This study evaluates two strength training protocols (one in peripheral muscles and one in inspiratory muscles) in the improvement of skeletal muscle mass and function in institutionalized elderly with sarcopenia. Participants will be assigned randomly in a control or one of both experimental groups.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * People aged \> 65 years * Sarcopenia diagnosis (Tyrovolas et al., 2015) * Medically stable at least 2 months before the study Exclusion Criteria: * Cardiorespiratory, muscular, neurological, or neuromuscular disease that could interfere in the proper performance of assessment and/or training protocols. * Endocrine and metabolic disorders that might have had an effect on muscle mass. * Severe disorder of hydration status that could interfere in Bioelectrical Impedance Analysis (Rubbieri et al., 2014). * A terminal disease diagnosis. * Mini-Mental State Examination Index ≤ 20 score.

What they're measuring

Change in Muscle mass

Timeframe: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).

Change in Maximum Respiratory Pressures (MIP and MEP)

Timeframe: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).

Change in Handgrip strength

Timeframe: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).

Change in peripheral muscle strength

Timeframe: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).

Trial details

NCT IDNCT02120586

SponsorUniversity of Valencia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-03

View on ClinicalTrials.gov More Sarcopenia trials

Plain-language summary

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in Muscle mass

Timeframe: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).

Change in Maximum Respiratory Pressures (MIP and MEP)

Timeframe: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).

Change in Handgrip strength

Timeframe: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).

Change in peripheral muscle strength

Timeframe: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).